{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:41:24Z","timestamp":1791754884429,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glycogen storage disease type Ia (GSDIa, von Gierke disease) is the most common glycogen storage disorder. It is caused by the deficiency of glucose-6-phosphatase, an enzyme which catalyses the final step of gluconeogenesis and glycogenolysis. Clinically, GSDIa is characterized by fasting hypoglycaemia and hepatic glycogen and triglyceride overaccumulation. The latter leads to steatohepatitis, cirrhosis, and the formation of hepatic adenomas and carcinomas. Currently, little is known about the function of various organelles and their impact on metabolism in GSDIa. Accordingly, we investigated mitochondrial function in cell culture and mouse models of GSDIa. We found impairments in oxidative phosphorylation and changes in TCA cycle metabolites, as well as decreased mitochondrial membrane potential and deranged mitochondrial ultra-structure in these model systems. Mitochondrial content also was decreased, likely secondary to decreased mitochondrial biogenesis. These deleterious effects culminated in the activation of the mitochondrial apoptosis pathway. Taken together, our results demonstrate a role for mitochondrial dysfunction in the pathogenesis of GSDIa, and identify a new potential target for the treatment of this disease. They also provide new insight into the role of carbohydrate overload on mitochondrial function in other hepatic diseases, such as non-alcoholic fatty liver disease.<\/jats:p>","DOI":"10.1038\/srep44408","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T10:23:43Z","timestamp":1490005423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)"],"prefix":"10.1038","volume":"7","author":[{"given":"Benjamin L.","family":"Farah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit A.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Huat","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"BFsrep44408_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1566524024605798","volume":"2","author":"JY Chou","year":"2002","unstructured":"Chou, J. Y., Matern, D., Mansfield, B. C. & Chen, Y. T. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Current molecular medicine 2, 121\u2013143 (2002).","journal-title":"Current molecular medicine"},{"key":"BFsrep44408_CR2","first-page":"497","volume":"82","author":"E von Gierke","year":"1929","unstructured":"von Gierke, E. Hepato-nephromegalia glykogenica (Glykogenspeicherkrankheit der Leber und Nieren). Beitr\u00e4ge zur pathologischen Anatomie und zur allgemeinen Pathologie 82, 497\u2013513 (1929).","journal-title":"Beitr\u00e4ge zur pathologischen Anatomie und zur allgemeinen Pathologie"},{"key":"BFsrep44408_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrendo.2010.189","volume":"6","author":"JY Chou","year":"2010","unstructured":"Chou, J. Y., Jun, H. S. & Mansfield, B. C. Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy. Nature reviews. Endocrinology 6, 676\u2013688, doi: 10.1038\/nrendo.2010.189 (2010).","journal-title":"Nature reviews. Endocrinology"},{"key":"BFsrep44408_CR4","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00431-002-1007-8","volume":"161","author":"RH Bandsma","year":"2002","unstructured":"Bandsma, R. H., Smit, G. P. & Kuipers, F. Disturbed lipid metabolism in glycogen storage disease type 1. European journal of pediatrics 161 Suppl 1, S65\u201369, doi: 10.1007\/s00431-002-1007-8 (2002).","journal-title":"European journal of pediatrics"},{"key":"BFsrep44408_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ymben.2009.01.003","volume":"11","author":"JG Jones","year":"2009","unstructured":"Jones, J. G., Garcia, P., Barosa, C., Delgado, T. C. & Diogo, L. Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease. Metabolic engineering 11, 155\u2013162, doi: 10.1016\/j.ymben.2009.01.003 (2009).","journal-title":"Metabolic engineering"},{"key":"BFsrep44408_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart, R. et al. Glucose-6-phosphatase deficiency. Orphanet journal of rare diseases 6, 27, doi: 10.1186\/1750-1172-6-27 (2011).","journal-title":"Orphanet journal of rare diseases"},{"key":"BFsrep44408_CR7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0021-9258(18)38504-1","volume":"199","author":"GT Cori","year":"1952","unstructured":"Cori, G. T. & Cori, C. F. Glucose-6-phosphatase of the liver in glycogen storage disease. The Journal of biological chemistry 199, 661\u2013667 (1952).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep44408_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1203\/PDR.0b013e31816c9013","volume":"63","author":"RH Bandsma","year":"2008","unstructured":"Bandsma, R. H. et al. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatric research 63, 702\u2013707, doi: 10.1203\/PDR.0b013e31816c9013 (2008).","journal-title":"Pediatric research"},{"key":"BFsrep44408_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.ki.5002718","volume":"73","author":"WH Yiu","year":"2008","unstructured":"Yiu, W. H. et al. Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney international 73, 716\u2013723, doi: 10.1038\/sj.ki.5002718 (2008).","journal-title":"Kidney international"},{"key":"BFsrep44408_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","volume":"28","author":"LM Franco","year":"2005","unstructured":"Franco, L. M. et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. Journal of inherited metabolic disease 28, 153\u2013162, doi: 10.1007\/s10545-005-7500-2 (2005).","journal-title":"Journal of inherited metabolic disease"},{"key":"BFsrep44408_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2007.05.012","volume":"47","author":"SK Reddy","year":"2007","unstructured":"Reddy, S. K. et al. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Journal of hepatology 47, 658\u2013663, doi: 10.1016\/j.jhep.2007.05.012 (2007).","journal-title":"Journal of hepatology"},{"key":"BFsrep44408_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0041-1345(02)03951-9","volume":"35","author":"PP Liu","year":"2003","unstructured":"Liu, P. P. et al. Outcome of living donor liver transplantation for glycogen storage disease. Transplantation proceedings 35, 366\u2013368 (2003).","journal-title":"Transplantation proceedings"},{"key":"BFsrep44408_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","volume":"30","author":"DD Koeberl","year":"2007","unstructured":"Koeberl, D. D., Kishnani, P. S. & Chen, Y. T. Glycogen storage disease types I and II: treatment updates. Journal of inherited metabolic disease 30, 159\u2013164, doi: 10.1007\/s10545-007-0519-9 (2007).","journal-title":"Journal of inherited metabolic disease"},{"key":"BFsrep44408_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/BJ20101225","volume":"432","author":"A Grefhorst","year":"2010","unstructured":"Grefhorst, A. et al. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor alpha (LXRalpha) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1. The Biochemical journal 432, 249\u2013254, doi: 10.1042\/BJ20101225 (2010).","journal-title":"The Biochemical journal"},{"key":"BFsrep44408_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ymgme.2009.04.003","volume":"97","author":"B Sun","year":"2009","unstructured":"Sun, B. et al. Activation of glycolysis and apoptosis in glycogen storage disease type Ia. Molecular genetics and metabolism 97, 267\u2013271, doi: 10.1016\/j.ymgme.2009.04.003 (2009).","journal-title":"Molecular genetics and metabolism"},{"key":"BFsrep44408_CR16","doi-asserted-by":"crossref","unstructured":"Farah, B. L. et al. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency. Journal of hepatology, doi: 10.1016\/j.jhep.2015.10.008 (2015).","DOI":"10.1016\/j.jhep.2015.10.008"},{"key":"BFsrep44408_CR17","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/circresaha.116.305420","volume":"116","author":"RB Vega","year":"2015","unstructured":"Vega, R. B., Horton, J. L. & Kelly, D. P. Maintaining ancient organelles: mitochondrial biogenesis and maturation. Circulation research 116, 1820\u20131834, doi: 10.1161\/circresaha.116.305420 (2015).","journal-title":"Circulation research"},{"key":"BFsrep44408_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1126\/science.aac7516","volume":"349","author":"RN Lightowlers","year":"2015","unstructured":"Lightowlers, R. N., Taylor, R. W. & Turnbull, D. M. Mutations causing mitochondrial disease: What is new and what challenges remain? Science 349, 1494\u20131499, doi: 10.1126\/science.aac7516 (2015).","journal-title":"Science"},{"key":"BFsrep44408_CR19","doi-asserted-by":"crossref","unstructured":"Rieusset, J. Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles? Diabetes & metabolism, doi: 10.1016\/j.diabet.2015.02.006 (2015).","DOI":"10.1016\/j.diabet.2015.02.006"},{"key":"BFsrep44408_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jconrel.2015.03.036","volume":"207","author":"L Milane","year":"2015","unstructured":"Milane, L., Trivedi, M., Singh, A., Talekar, M. & Amiji, M. Mitochondrial biology, targets, and drug delivery. Journal of controlled release: official journal of the Controlled Release Society 207, 40\u201358, doi: 10.1016\/j.jconrel.2015.03.036 (2015).","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"BFsrep44408_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-94-007-2869-1_7","volume":"942","author":"J Estaquier","year":"2012","unstructured":"Estaquier, J., Vallette, F., Vayssiere, J. L. & Mignotte, B. The mitochondrial pathways of apoptosis. Advances in experimental medicine and biology 942, 157\u2013183, doi: 10.1007\/978-94-007-2869-1_7 (2012).","journal-title":"Advances in experimental medicine and biology"},{"key":"BFsrep44408_CR22","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.181.5.1661","volume":"181","author":"N Zamzami","year":"1995","unstructured":"Zamzami, N. et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo . The Journal of experimental medicine 181, 1661\u20131672 (1995).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep44408_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","volume":"86","author":"X Liu","year":"1996","unstructured":"Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147\u2013157 (1996).","journal-title":"Cell"},{"key":"BFsrep44408_CR24","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1093\/emboj\/16.15.4639","volume":"16","author":"RM Kluck","year":"1997","unstructured":"Kluck, R. M. et al. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. The EMBO journal 16, 4639\u20134649, doi: 10.1093\/emboj\/16.15.4639 (1997).","journal-title":"The EMBO journal"},{"key":"BFsrep44408_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0344-0338(80)80185-3","volume":"167","author":"UN Riede","year":"1980","unstructured":"Riede, U. N., Spycher, M. A. & Gitzelmann, R. Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells. Pathology, research and practice 167, 136\u2013150, doi: 10.1016\/S0344-0338(80)80185-3 (1980).","journal-title":"Pathology, research and practice"},{"key":"BFsrep44408_CR26","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1182\/blood-2009-12-258491","volume":"116","author":"HS Jun","year":"2010","unstructured":"Jun, H. S. et al. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood 116, 2783\u20132792, doi: 10.1182\/blood-2009-12-258491 (2010).","journal-title":"Blood"},{"key":"BFsrep44408_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","volume":"13","author":"DD Koeberl","year":"2006","unstructured":"Koeberl, D. D. et al. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene therapy 13, 1281\u20131289, doi: 10.1038\/sj.gt.3302774 (2006).","journal-title":"Gene therapy"},{"key":"BFsrep44408_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng0696-203","volume":"13","author":"KJ Lei","year":"1996","unstructured":"Lei, K. J. et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nature genetics 13, 203\u2013209, doi: 10.1038\/ng0696-203 (1996).","journal-title":"Nature genetics"},{"key":"BFsrep44408_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bj1200105","volume":"120","author":"DA Hems","year":"1970","unstructured":"Hems, D. A. & Brosnan, J. T. Effects of ischaemia on content of metabolites in rat liver and kidney in vivo . The Biochemical journal 120, 105\u2013111 (1970).","journal-title":"The Biochemical journal"},{"key":"BFsrep44408_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1083\/jcb.37.2.345","volume":"37","author":"CR Hackenbrock","year":"1968","unstructured":"Hackenbrock, C. R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. II. Electron transport-linked ultrastructural transformations in mitochondria. The Journal of cell biology 37, 345\u2013369 (1968).","journal-title":"The Journal of cell biology"},{"key":"BFsrep44408_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.bbamcr.2006.02.006","volume":"1763","author":"HM Heath-Engel","year":"2006","unstructured":"Heath-Engel, H. M. & Shore, G. C. Mitochondrial membrane dynamics, cristae remodelling and apoptosis. Biochimica et biophysica acta 1763, 549\u2013560, doi: 10.1016\/j.bbamcr.2006.02.006 (2006).","journal-title":"Biochimica et biophysica acta"},{"key":"BFsrep44408_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461, doi: 10.1126\/science.1196371 (2011).","journal-title":"Science"},{"key":"BFsrep44408_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-61779-328-8_21","volume":"793","author":"J Zhu","year":"2011","unstructured":"Zhu, J., Dagda, R. K. & Chu, C. T. Monitoring mitophagy in neuronal cell cultures. Methods in molecular biology 793, 325\u2013339, doi: 10.1007\/978-1-61779-328-8_21 (2011).","journal-title":"Methods in molecular biology"},{"key":"BFsrep44408_CR34","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1074\/jbc.M212923200","volume":"278","author":"SN Schreiber","year":"2003","unstructured":"Schreiber, S. N., Knutti, D., Brogli, K., Uhlmann, T. & Kralli, A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). The Journal of biological chemistry 278, 9013\u20139018, doi: 10.1074\/jbc.M212923200 (2003).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep44408_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","volume":"74","author":"AH Bhat","year":"2015","unstructured":"Bhat, A. H. et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie 74, 101\u2013110, doi: 10.1016\/j.biopha.2015.07.025 (2015).","journal-title":"Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie"},{"key":"BFsrep44408_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Molecular cell 44, 177\u2013190, doi: 10.1016\/j.molcel.2011.07.019 (2011).","journal-title":"Molecular cell"},{"key":"BFsrep44408_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.exger.2014.08.008","volume":"58","author":"L Lozano","year":"2014","unstructured":"Lozano, L., Lara-Lemus, R., Zenteno, E. & Alvarado-Vasquez, N. The mitochondrial O-linked N-acetylglucosamine transferase (mOGT) in the diabetic patient could be the initial trigger to develop Alzheimer disease. Experimental gerontology 58, 198\u2013202, doi: 10.1016\/j.exger.2014.08.008 (2014).","journal-title":"Experimental gerontology"},{"key":"BFsrep44408_CR38","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li, Z., Berk, M., McIntyre, T. M., Gores, G. J. & Feldstein, A. E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 47, 1495\u20131503, doi: 10.1002\/hep.22183 (2008).","journal-title":"Hepatology"},{"key":"BFsrep44408_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers, S. A. Ceramides in insulin resistance and lipotoxicity. Progress in lipid research 45, 42\u201372, doi: 10.1016\/j.plipres.2005.11.002 (2006).","journal-title":"Progress in lipid research"},{"key":"BFsrep44408_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200412022","volume":"169","author":"M Komatsu","year":"2005","unstructured":"Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. The Journal of cell biology 169, 425\u2013434, doi: 10.1083\/jcb.200412022 (2005).","journal-title":"The Journal of cell biology"},{"key":"BFsrep44408_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/en.2015-1632","volume":"157","author":"R Lesmana","year":"2016","unstructured":"Lesmana, R. et al. Thyroid Hormone Stimulation of Autophagy Is Essential for Mitochondrial Biogenesis and Activity in Skeletal Muscle. Endocrinology 157, 23\u201338, doi: 10.1210\/en.2015-1632 (2016).","journal-title":"Endocrinology"},{"key":"BFsrep44408_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3748\/wjg.14.193","volume":"14","author":"Y Wei","year":"2008","unstructured":"Wei, Y., Rector, R. S., Thyfault, J. P. & Ibdah, J. A. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World journal of gastroenterology 14, 193\u2013199 (2008).","journal-title":"World journal of gastroenterology"},{"key":"BFsrep44408_CR43","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1053\/j.gastro.2005.02.001","volume":"128","author":"JA Ibdah","year":"2005","unstructured":"Ibdah, J. A. et al. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128, 1381\u20131390 (2005).","journal-title":"Gastroenterology"},{"key":"BFsrep44408_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jhep.2009.05.026","volume":"51","author":"SK Reddy","year":"2009","unstructured":"Reddy, S. K. et al. Liver transplantation for glycogen storage disease type Ia. Journal of hepatology 51, 483\u2013490, doi: 10.1016\/j.jhep.2009.05.026 (2009).","journal-title":"Journal of hepatology"},{"key":"BFsrep44408_CR45","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.pediatrneurol.2014.06.023","volume":"52","author":"J Finsterer","year":"2015","unstructured":"Finsterer, J. & Bindu, P. S. Therapeutic strategies for mitochondrial disorders. Pediatric neurology 52, 302\u2013313, doi: 10.1016\/j.pediatrneurol.2014.06.023 (2015).","journal-title":"Pediatric neurology"},{"key":"BFsrep44408_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/hum.2011.106","volume":"23","author":"A Demaster","year":"2012","unstructured":"Demaster, A. et al. Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia. Human gene therapy 23, 407\u2013418, doi: 10.1089\/hum.2011.106 (2012).","journal-title":"Human gene therapy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep44408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44408","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T23:50:40Z","timestamp":1671839440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep44408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,6,1]]}},"alternative-id":["BFsrep44408"],"URL":"https:\/\/doi.org\/10.1038\/srep44408","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"assertion":[{"value":"29 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44408"}}